68Ga-纳米胶体PET/CT前列腺癌前哨淋巴结显像首次人体研究显示异常淋巴引流途径
该首次人体先导研究纳入5例需植入金标行前列腺癌放疗的患者,经超声引导经会阴前列腺内注射68Ga-纳米胶体后行PET/CT淋巴显像,5例均成功识别前哨淋巴结,未观察到不良反应,并发现骨盆骨、精囊周围、直肠系膜、腹股沟及Virchow淋巴结等非传统引流途径。
要点
- 5例患者均成功识别前哨淋巴结,未观察到不良反应。
- 发现骨盆骨、精囊周围、直肠系膜、腹股沟及Virchow淋巴结等非传统引流途径。
- 作者认为异常及非淋巴播散途径的患病率需用该技术进一步研究。
核心结论
- 68Ga-纳米胶体PET/CT可成功进行前哨淋巴结识别。
- 发现了包括骨盆骨及精囊周围、直肠系膜、腹股沟和Virchow淋巴结在内的非传统疾病播散途径。
- 作者认为异常及非淋巴播散途径的患病率需用该技术进一步研究。
研究设计与样本
- 来自一家三级癌症医院、需植入金标行前列腺癌放疗的患者参加的先导研究。
- 参与不影响癌症管理。
- 植入金标后行超声引导经会阴前列腺内注射68Ga标记的氧化铁纳米胶体。
- 注射后约45分钟和100分钟行PET/CT淋巴显像。
- 研究采用贝叶斯设计监测,假设在超过80%置信度下至少三分之二病例可识别至少1枚前哨淋巴结。
主要发现
- 全部5例参与者前哨淋巴结识别成功,按方案完成先导研究。
- 未观察到不良反应。
- 发现预期区域引流途径及意外的潜在恶性细胞转运途径。
- 识别到示踪剂快速引流至骨盆骨、精囊周围、直肠系膜、腹股沟和Virchow淋巴结。
局限性
- 作者认为异常及非淋巴播散途径的患病率需用该技术进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our goal was to assess the feasibility, safety, and utility of a novel 68Ga-nanocolloid radiotracer with PET/CT lymphoscintigraphy for identification of sentinel lymph nodes (SLNs). Methods: This was a pilot study of patients from a tertiary cancer hospital who required insertion of gold fiducials for prostate cancer radiation therapy. Participation did not affect cancer management. Ultrasound-guided transperineal intraprostatic injection of a PET tracer (iron oxide nanocolloid labeled with 68Ga) was performed after placement of the fiducials. PET/CT lymphoscintigraphy imaging took place at approximately 45 and 100 min after injection of the tracer. The study was monitored using a Bayesian design with the assumption that at least 1 SLN could be identified in at least two thirds of cases with more than 80% confidence. Results: SLN identification was successful in all 5 participants, allowing completion of the pilot study as per protocol. No adverse effects were observed. Unexpected potential pathways for transit of malignant cells, as well as the expected regional drainage pathways, were discovered. Rapid tracer drainage to pelvic bone, perivesicular, mesorectal, inguinal, and Virchow nodes was identified. Conclusion: SLN identification using 68Ga-nanocolloid PET/CT can be successfully performed. Nontraditional pathways of disease spread were identified, including drainage to pelvic bone and to perivesicular, mesorectal, inguinal, and Virchow nodes. The prevalence of both aberrant and nonlymphatic pathways of spread should be further investigated with this technique.
引用
- Doughton JA, Hofman MS, Eu P, et al. A First-in-Human Study of 68Ga-Nanocolloid PET/CT Sentinel Lymph Node Imaging in Prostate Cancer Demonstrates Aberrant Lymphatic Drainage Pathways. J Nucl Med. 2018. PMID: 29728517. doi:10.2967/jnumed.118.209171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。